Cord Blood America Spokesperson to Hold Webinar on Banking Stem Cells at Birth
LAS VEGAS, June 16 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI) (www.cordblood-america.com) is pleased to announce that Natalie Curry, the Company's official spokesperson and medically saved by the first umbilical cord blood collection in the world, will discuss a wide range of topics about cord blood banking live from CBAI's laboratory in Las Vegas.
The live Webinar will occur at 3 p.m. Pacific (6 p.m. Eastern) on Wednesday, June 16, 2010, and can be viewed at http://www.allaboutcordblood.com . Questions can be e-mailed to Ms. Curry before and during the Webinar at [email protected] .
"Natalie was diagnosed at age one with Fanconi's Anemia, a rare, but certain to be fatal blood disorder. In 1989, her sister's umbilical cord blood was used in a medical first, a transplant operation that saved her life," said Matthew Schissler, Cord Blood America CEO and co-founder. "Additional information about this event, and the importance of saving umbilical cord blood stem cells at birth, is available at http://www.nataliecurry.com/ .
"We believe the more people know about the life saving potential of stem cells, a real life biological insurance policy, the more likely they are to make the correct decision to store their babies' umbilical cord blood stem cells at birth. We have asked Natalie to hold Webinars, to blog and to write articles about this important medical advance. We invite everyone to join and hear for themselves, firsthand, the tremendous story of cord blood stem cells," Mr. Schissler said.
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit www.cordblood-america.com.
CONTACT: |
|
Paul Knopick |
|
E & E Communications |
|
949/707-5365 |
|
SOURCE Cord Blood America, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article